Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
View ORCID ProfileMatthias Becker, Anne Cossmann, Karsten Lürken, Daniel Junker, Jens Gruber, Jennifer Juengling, Gema Morillas Ramos, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Metodi V. Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gérard Krause, View ORCID ProfileNicole Schneiderhan-Marra, Monika Strengert, Alex Dulovic, Georg M.N. Behrens
doi: https://doi.org/10.1101/2022.07.13.22277581
Matthias Becker
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(MSc)Anne Cossmann
bDepartment for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
(BSc)Karsten Lürken
cDialysis Centre Eickenhof, Langenhagen, Germany
(MD)Daniel Junker
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(MSc)Jens Gruber
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(MSc)Jennifer Juengling
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(Dipl.-Biol)Gema Morillas Ramos
bDepartment for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
(MSc)Andrea Beigel
cDialysis Centre Eickenhof, Langenhagen, Germany
(MD)Eike Wrenger
cDialysis Centre Eickenhof, Langenhagen, Germany
(MD)Gerhard Lonnemann
cDialysis Centre Eickenhof, Langenhagen, Germany
(MD)Metodi V. Stankov
bDepartment for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
(PhD)Alexandra Dopfer-Jablonka
bDepartment for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
fGerman Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany
(MD)Philipp D. Kaiser
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(PhD)Bjoern Traenkle
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(PhD)Ulrich Rothbauer
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
ePharmaceutical Biotechnology, University of Tübingen, Germany
(PhD)Gérard Krause
fGerman Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany
gHelmholtz Centre for Infection Research, Braunschweig, Germany
hTWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
(MD)Nicole Schneiderhan-Marra
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(PhD)Monika Strengert
gHelmholtz Centre for Infection Research, Braunschweig, Germany
hTWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
(PhD)Alex Dulovic
aNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
(PhD)Georg M.N. Behrens
bDepartment for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
dCiiM - Centre for Individualized Infection Medicine, Hannover, Germany
fGerman Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany
(MD)Data Availability
Data relating to the findings of this study are available from the corresponding authors upon request.
Posted July 15, 2022.
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
Matthias Becker, Anne Cossmann, Karsten Lürken, Daniel Junker, Jens Gruber, Jennifer Juengling, Gema Morillas Ramos, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Metodi V. Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra, Monika Strengert, Alex Dulovic, Georg M.N. Behrens
medRxiv 2022.07.13.22277581; doi: https://doi.org/10.1101/2022.07.13.22277581
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
Matthias Becker, Anne Cossmann, Karsten Lürken, Daniel Junker, Jens Gruber, Jennifer Juengling, Gema Morillas Ramos, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Metodi V. Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra, Monika Strengert, Alex Dulovic, Georg M.N. Behrens
medRxiv 2022.07.13.22277581; doi: https://doi.org/10.1101/2022.07.13.22277581
Subject Area
Subject Areas
- Addiction Medicine (361)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2710)
- Dermatology (232)
- Emergency Medicine (409)
- Epidemiology (12351)
- Forensic Medicine (10)
- Gastroenterology (778)
- Genetic and Genomic Medicine (4202)
- Geriatric Medicine (394)
- Health Economics (693)
- Health Informatics (2714)
- Health Policy (1012)
- Hematology (366)
- HIV/AIDS (871)
- Medical Education (402)
- Medical Ethics (111)
- Nephrology (447)
- Neurology (3983)
- Nursing (216)
- Nutrition (588)
- Oncology (2099)
- Ophthalmology (598)
- Orthopedics (249)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (77)
- Pathology (474)
- Pediatrics (1138)
- Primary Care Research (464)
- Public and Global Health (6610)
- Radiology and Imaging (1432)
- Respiratory Medicine (879)
- Rheumatology (417)
- Sports Medicine (348)
- Surgery (458)
- Toxicology (57)
- Transplantation (192)
- Urology (170)